AOD 9604 5mg Canada – Research Use Only

Description

Buy AOD 9604 5mg Canada – Laboratory Research Material

Buy AOD 9604 5mg Canada from Nordexa Research for laboratory research and analytical evaluation only. This standalone 5mg format is supplied as lyophilized research material in a sealed 3 mL vial. Orders ship from Ontario, and the live verification panel on this page displays the current batch documentation for the inventory being supplied.

This listing gives qualified purchasers a clear compound identity, format, research-use boundary, and direct access to current documentation without embedding temporary batch details in the permanent description.

AOD 9604 5mg Product Details

• Product: AOD 9604 research material
• Alternate styling: AOD-9604 and AOD9604
• Listed quantity: 5mg per vial
• Form: Lyophilized material
• Container: Sealed 3 mL vial
• Fulfilment: Ships from Ontario, Canada
• Documentation: Current third-party batch information is displayed in the live verification panel
• Intended use: Laboratory research and analytical evaluation only
• Purchaser requirement: 21+

What Is AOD-9604?

AOD-9604 is catalogued by the NIH PubChem database as a 16-amino-acid synthetic analogue related to the C-terminal region of human growth hormone. PubChem lists the sequence YLRIVQCRSVEGSCGF and identifies an intramolecular disulfide connection between the two cysteine residues. Researchers can review the chemical record at PubChem CID 71300630.

AOD 9604, AOD-9604, and AOD9604 are common text variations used for the same catalogue reference. The compound should not be confused with full-length human growth hormone or an unmodified fragment bearing a different sequence.

AOD-9604 Compound and Research Context

A 2001 study compared human growth hormone and AOD9604 in obese mouse models, including beta-3 adrenergic receptor knockout mice. The researchers measured body composition, lipid-metabolism markers, receptor expression, and related experimental endpoints after defined treatments. The primary publication is available through PubMed PMID 11713213.

Those findings are specific to the animal models, experimental conditions, routes, durations, and endpoints used by the researchers. They are not evidence of human weight loss, a therapeutic benefit, a safety conclusion, or product performance for the AOD 9604 5mg research material listed here. Nordexa does not translate preclinical observations into personal-use guidance.

Current Batch Verification

The live verification panel displays the current third-party documentation associated with the inventory being supplied. Review the active batch identifier, measured results, and available reports before ordering, then compare the panel’s batch identifier with the delivered vial label.

The panel updates independently when released inventory changes. This keeps temporary laboratory names, batch numbers, testing dates, measured values, report counts, and report URLs out of the permanent product description while allowing the current record to remain available on the live page.

Standalone AOD 9604 5mg Canada Format

This page applies only to the standalone AOD 9604 5mg Canada format. It is not a blend and should not be treated as documentation for full-length growth hormone, another fragment, or a differently identified compound. The product name, PubChem identity record, vial label, and current verification panel should be reviewed together.

Researchers comparing separate catalogue materials may review the individual Cagrilintide 10mg Canada, Semaglutide 10mg Canada, and Tirzepatide 10mg Canada pages. These are distinct compounds. The links do not suggest equivalence, combined use, a protocol, or a research outcome.

Ordering AOD 9604 5mg Research Material in Canada

Before placing an AOD-9604 5mg research peptide order, confirm the product title, listed quantity, vial format, live availability, current verification record, and shipping details shown on this page. Availability and batch documentation can change as inventory is allocated, so the live page should be reviewed at the time of purchase.

For order-specific documentation questions, contact Nordexa Support with the product name, order number, and batch identifier visible on the delivered vial. Retaining the vial label provides the clearest reference when comparing a received item with the posted record.

Frequently Asked Questions

Are AOD 9604, AOD-9604, and AOD9604 the same catalogue name?

They are common punctuation variations used for the compound listed by PubChem as CID 71300630.

What sequence does PubChem list for AOD-9604?

PubChem identifies the 16-residue sequence as YLRIVQCRSVEGSCGF and shows a disulfide connection between its two cysteine residues.

Where is current AOD 9604 batch testing displayed?

Current documentation is displayed in the live verification panel on this page. Compare its batch identifier with the delivered vial label before relying on the record.

Does the cited animal study establish a human outcome?

No. It reports measurements from defined mouse models and is provided as research context, not as medical guidance or a claim about this product.

Research-Use Boundary

This AOD 9604 5mg Canada product is sold strictly for laboratory research and analytical evaluation by qualified purchasers aged 21 or older. It is not for human or animal consumption, therapeutic use, diagnostic use, cosmetic use, compounding, or personal experimentation.

Nordexa does not provide preparation, reconstitution, dilution, dosing, administration, cycle, protocol, or personal-use guidance. Purchasers are responsible for applicable institutional procedures, regulations, and independent laboratory safety requirements.

Compliance notice: For laboratory research use only. Not for human or animal consumption. Must be 21+ to order. Ships from Ontario, Canada.